Doripenem

Chemical formula: C₁₅H₂₄N₄O₆S₂  Molecular mass: 420.504 g/mol  PubChem compound: 73303

Therapeutic indications

Doripenem is indicated for:

Nosocomial pneumonia

Population group: only adults (18 years old or older)

Nosocomial pneumonia (including ventilator–associated pneumonia).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Complicated intra-abdominal infections

Population group: only adults (18 years old or older)

Infectious disease of abdomen and additionally at least one of
Doripenem susceptible species
Doripenem susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Complicated urinary tract infections

Population group: only adults (18 years old or older)

Urinary tract infectious disease and additionally at least one of
Doripenem susceptible species
Doripenem susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Doripenem is contraindicated in the following cases:

Hypersensitivity to any carbapenem antibacterial agent

Carbapenem allergy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2014: DORIBAX Powder for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈